SEKISUI Diagnostics
Jason Bilobram has extensive experience in quality management and regulatory compliance. Jason began their career at AstraZeneca in 1993 as a Supervisor of Quality and Manufacturing Engineering. Jason then moved on to Saint-Gobain Performance Plastics in 1998, where they served as the Manager of Quality and Regulatory, focusing on the life sciences industry. In 2001, they joined Smith & Nephew as the Director of Quality and Regulatory, overseeing various medical technology sectors. In 2014, Bilobram started their own company called Quality Management Solutions, where they served as the Owner and Principal Consultant, providing expertise in quality management systems and regulatory submissions. Currently, Bilobram holds the position of Vice President of Quality, Regulatory, and Compliance at SEKISUI Diagnostics, a global corporation specializing in chemical solutions and life sciences.
Jason Bilobram has a Bachelor of Science (BSc) degree in Molecular Biology from the University of Rhode Island. Jason also completed a minor in Organic Chemistry during their time there. Afterward, they pursued a Master of Science (MS) degree in Biological and Biomedical Sciences through Brown University/URI Programs. In addition to their formal education, Jason has obtained certifications in Lean and Six Sigma as a Champion from Juran Global in March 2016, and RAC certification from the Regulatory Affairs Professionals Society (RAPS) in November 2002.
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals